Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Nivolumab 2Magnetic Resonance Spectroscopy 2trastuzumab deruxtecan 1tamibarotene 1cabozantinib 1Ultrasonography 1Specimen Handling 1Ipilimumab 1Cisplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Urethral Neoplasms × tamibarotene × Clear all
NCT06983210 2025-08-14

GRAPE

Nagoya University

Phase 2 Recruiting
43 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡